| 
Start-up Australia is a specialist venture capital company which invests in innovative
life science companies which have high growth prospects. These companies may operate in a
range of sectors including; human health, animal health, agritech and environmental
technology. As our portfolio companies have grown in value, we have been able to deliver
attractive financial returns to our investors.
Click here if you would
like to subscribe to our quarterly newsletter.
Latest News
Positive new data on BNC210 presented
at conference.
BNC105 commences US clinical trials
in renal cancer.
Start-up Australia wins "Private
Equity Exit of the Year".
First stage of BNC210 clinical trial
successfully completed.
New data on anxiety drug to be
presented at international conference.
Bionomics $15 million capital
raising.
Start-up Australia Ventures Pty Ltd
Placement in Bionomics.
Bionomics to undertake US clinical
trial on BNC210 in renal cell cancer.
Phase I clinical trial on Bionomics'
anti-anxiety drug BNC210 initiated.
Initial Phase I data on cancer drug
presented.
Anti-anxiety drug approved to enter
human clinical trials.
Cephalon offer for Arana goes
unconditional.
Fondaparinux ANDA accepted by FDA for
review
Bionomics: New data on BNC105
presented to AACR.
Alchemia and SDP Technology enter
cancer drug collaboration.
Alchemia announces filing of
Abbreviated New Drug Application to FDA for fondaparinux.
|
